Drug Trial Radar · NCT07545772
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
342
Planned (sponsor's estimate)
Start
Apr 29, 2026
Primary completion
Jul 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Apr 22, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate how well brenipatide (LY3537031) is tolerated what side effects may occur, and the safety and efficacy in participants with Irritable Bowel Syndrome-Constipation (IBS-C). The study drug will be administered subcutaneously (SC) (under the skin) when compared with placebo. The study will last approximately 36 weeks.
Conditions
- Irritable Bowel Syndrome
- Constipation
Interventions
LY3537031Drug
Administered SC.
PlaceboDrug
Administered SC.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants with a Weekly Composite Clinical Response for at Least 50 Percent (%) of WeeksTime frame: Week 9 to 16
Locations
70 sites in 8 countries. Site status is shown where the registry gives one.
Del Sol Research Management - Mesa
Mesa, Arizona · Recruiting
Smart Cures Clinical Research
Anaheim, California · Recruiting
Om Research LLC
Lancaster, California · Recruiting
United Medical Doctors - Los Alamitos
Los Alamitos, California · Recruiting
Encore Medical Research
Hollywood, Florida · Recruiting
Springfield Clinic - First
Springfield, Illinois · Recruiting
Gastroenterology Health Partners
New Albany, Indiana · Recruiting
Gastroenterology Health Partners
Louisville, Kentucky · Recruiting
New York Gastroenterology Associates
New York, New York · Recruiting
Ohio Gastroenterology
Columbus, Ohio · Recruiting
University Gastroenterology
Providence, Rhode Island · Recruiting
Biopharma Informatic, LLC
McAllen, Texas · Recruiting
Southern Star Research Institute
San Antonio, Texas · Recruiting
GI Alliance-Webster
Webster, Texas · Recruiting
Sint Vincentius Ziekenhuis
Antwerp, Belgium · Not yet recruiting
AZ Sint-Lucas
Bruges, Belgium · Not yet recruiting
UZ Brussel
Brussels, Belgium · Not yet recruiting
Antwerp University Hospital
Edegem, Belgium · Not yet recruiting
AZ Maria Middelares
Ghent, Belgium · Recruiting
AZ Sint-Lucas
Ghent, Belgium · Recruiting
UZ Gent
Ghent, Belgium · Not yet recruiting
UZ Leuven
Leuven, Belgium · Recruiting
Clinical Chc Montlégia
Liège, Belgium · Recruiting
AZ Delta vzw
Roeselare, Belgium · Recruiting
Bluewater Clinical Research Group Inc.
Sarnia, Canada · Recruiting
Scarborough Center for Inflammatory Bowel Disease
Scarborough, Canada · Recruiting
ClinSurge Research - LMC Scarborough / Malvern Medical Centre
Scarborough, Canada · Recruiting
Stouffville Medical Research Institute Inc.
Stouffville, Canada · Recruiting
Canadian Phase Onward
Toronto, Canada · Recruiting
Binzhou Medical University Hospital
Binzhou, China · Recruiting
Sichuan Provincial People's Hospital
Chengdu, China · Recruiting
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, China · Recruiting
Zhejiang Hospital of Traditioal Chinese Medicine
Hangzhou, China · Recruiting
The Second Affiliated Hospital of University of South China
Hengyang, China · Recruiting
Huizhou Central People's Hospital
Huizhou, China · Recruiting
Huzhou Central Hospital
Huzhou, China · Recruiting
Meihekou Central Hospital
Meihekou, China · Recruiting
Quzhou People's Hospital
Quzhou, China · Recruiting
Taian City Central Hospital
Taian, China · Recruiting
Xianning Central Hospital
Xianning, China · Recruiting
Showing 40 of 70 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.